You may be familiar with semaglutide, known by its brand name Ozempic for diabetes and Wegovy for weight management
The regulatory landscape could change at any time, potentially affecting medication availability, pricing, and the providers themselves
Doctors in the United States can prescribe medicines for uses beyond those approved by the FDA
This medication is administered as a weekly subcutaneous injection with doses ranging from 2.5 mg to 15 mg, titrated based on efficacy and tolerability
These hormones naturally slow digestion and signal fullness, which is why most side effects involve the gastrointestinal system
The post hoc analysis of the SUSTAIN 6 trial revealed that once-weekly semaglutide reduced the risk of major adverse cardiovascular events in all subjects, regardless of gender, age, or baseline cardiovascular risk